The aim of the present study is to find out the influence of sarcopenia on outcomes of neuroplasty in patients with lumbar spinal stenosis.
Age range
65 Years – 79 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in numeric rating scale (NRS) at 3 months after the procedure
Timeframe: Before the procedure and 3 months after the procedure
Change in Oswestry disability index (ODI) at 3 months after the procedure
Timeframe: Before the procedure and 3 months after the procedure
Global percieved effect (GPE) score at 3 months after the procedure
Timeframe: 3 months after the procedure
Change in Medication Quantification scale (MQS) at 3 months after the procedure
Timeframe: Before the procedure and 3 months after the procedure
The percentage of successful responders at 3 months after the procedure
Timeframe: 3 months after the procedure